LuciErda

药品简介

Originator: Balversa by Janssen · Manufacturer: Lucius Pharma. Indication & Dosage: LuciErda (Erdafitinib), generic Balversa is a prescription medicine used to treat adult patients with locally advanced or metastatic Urothelial Carcinoma (bladder cancer) that has susceptible FGFR3 or FGFR2 genetic alterations and progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy. LuciErda manufactured by Lucius Pharma in Laos. Erdafitinib has to take orally once daily with or without food. Side Effects: The most common adverse reactions of Erdafitinib are: Nausea , vomiting , mouth sores/pain , change in how food tastes, abdominal pain, diarrhea, constipation, loss of appetite, weight loss, tiredness, dry mouth/skin, or muscle/joint pain . The above information comes from the Internet. Please consult with doctor for medical advice.

本信息仅供参考，不构成医疗建议。请务必咨询合格的医疗专业人士。